MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202441000659 A) filed by Biophore India Pharmaceuticals Pvt. Ltd on January 04, 2024, for “process For The Preparation Of N-[4(chlorodifluoromethoxy)phenyl]-6-[(3r)- 3-Hydroxypyrrolidin-1-Yl]-5-(1h-Pyrazol-3-Yl) Pyridine-3-Carboxamide And Pharmaceutically Acceptable Salts Thereof”.

Inventors include Manik Reddy Pullagurla; Kiran Kumar Kothakonda; Bhaskar Reddy Pitta; and Jagadeesh Babu Rangisetty.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: ABSTRACT “PROCESS FOR THE PREPARATION OF N- [4(CHLORODIFLUOROMETHOXY)PHENYL]-6-[(3R)-3- HYDROXYPYRROLIDIN-1-YL]-5-(1H-PYRAZOL-3-YL) PYRIDINE-3- CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF” The present invention provides a process for the preparation of N- [4(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1Hpyrazol-3-yl) pyridine-3-carboxamide represented by compound of formula (1) and 5 pharmaceutically acceptable salts thereof.

Disclaimer: Curated by HT Syndication.